ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

Funding Opportunities: CDC Seeks Initiatives For Tobacco Control; NCI RFA Available

May 8, 1998

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Funding Opportunities: NCI Meeting Scheduled For Applicants Of RFA On Pediatric Consortium

February 27, 1998